Taiwo Oladapo

Array ( [id] => 6374552 [patent_doc_number] => 20100081151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'BIOMARKERS FOR EARLY DETECTION OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 12/630458 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24440 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081151.pdf [firstpage_image] =>[orig_patent_app_number] => 12630458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189621 [patent_doc_number] => 08183357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Antibodies that bind to EphA2 and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/627335 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27316 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183357.pdf [firstpage_image] =>[orig_patent_app_number] => 12627335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627282 [patent_doc_number] => 20100172939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Treating neoplasms with neurotoxin' [patent_app_type] => utility [patent_app_number] => 12/592540 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22203 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172939.pdf [firstpage_image] =>[orig_patent_app_number] => 12592540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046768 [patent_doc_number] => 20110206703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS' [patent_app_type] => utility [patent_app_number] => 13/127701 [patent_app_country] => US [patent_app_date] => 2009-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 34987 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206703.pdf [firstpage_image] =>[orig_patent_app_number] => 13127701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055075 [patent_doc_number] => 20110111435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Detecting Cell Surface Markers' [patent_app_type] => utility [patent_app_number] => 12/613798 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15629 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20110111435.pdf [firstpage_image] =>[orig_patent_app_number] => 12613798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977939 [patent_doc_number] => 08071717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/589647 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8691 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071717.pdf [firstpage_image] =>[orig_patent_app_number] => 12589647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6317027 [patent_doc_number] => 20100112582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'GENE ENCODING LABYRINTHIN, A MARKER FOR CANCER' [patent_app_type] => utility [patent_app_number] => 12/605185 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8439 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112582.pdf [firstpage_image] =>[orig_patent_app_number] => 12605185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007057 [patent_doc_number] => 20110059088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Protein involved in ovarian cancer' [patent_app_type] => utility [patent_app_number] => 12/587870 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16415 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059088.pdf [firstpage_image] =>[orig_patent_app_number] => 12587870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441747 [patent_doc_number] => 20100104588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'SERUM ALBUMIN BINDING PEPTIDES FOR TUMOR TARGETING' [patent_app_type] => utility [patent_app_number] => 12/578449 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 31916 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104588.pdf [firstpage_image] =>[orig_patent_app_number] => 12578449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6631535 [patent_doc_number] => 20100173297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'NOVEL SERPENTINE TRANSMEMBRANE ANTIGENS EXPRESSED IN HUMAN CANCERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/575164 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 21241 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173297.pdf [firstpage_image] =>[orig_patent_app_number] => 12575164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6468588 [patent_doc_number] => 20100190962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'NOVEL SERPENTINE TRANSMEMBRANE ANTIGENS EXPRESSED IN HUMAN CANCERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/575092 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 21240 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190962.pdf [firstpage_image] =>[orig_patent_app_number] => 12575092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10567399 [patent_doc_number] => 09290556 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-22 [patent_title] => 'Tumor vascular marker-targeted vaccines' [patent_app_type] => utility [patent_app_number] => 13/121638 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 50536 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13121638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6348598 [patent_doc_number] => 20100021468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANITGEN, NY ESO-1' [patent_app_type] => utility [patent_app_number] => 12/568134 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23627 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 46 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021468.pdf [firstpage_image] =>[orig_patent_app_number] => 12568134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992554 [patent_doc_number] => 20110014207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'COMBINATION TREATMENT FOR NON-HEMATOLOGIC MALIGNANCIES' [patent_app_type] => utility [patent_app_number] => 12/567040 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12279 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014207.pdf [firstpage_image] =>[orig_patent_app_number] => 12567040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685458 [patent_doc_number] => 20100120683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Prame derived peptides and immunogenic compositions comprising these' [patent_app_type] => utility [patent_app_number] => 12/586625 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16156 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120683.pdf [firstpage_image] =>[orig_patent_app_number] => 12586625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870361 [patent_doc_number] => 08465738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics' [patent_app_type] => utility [patent_app_number] => 12/564683 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 46 [patent_no_of_words] => 15187 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12564683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10620632 [patent_doc_number] => 09339560 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-17 [patent_title] => 'Method for determining the anti-tumor efficacy of monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 13/061770 [patent_app_country] => US [patent_app_date] => 2009-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2285 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13061770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8339940 [patent_doc_number] => 08241862 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Perinucleolar compartment as a cancer marker' [patent_app_type] => utility [patent_app_number] => 12/559634 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10817 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12559634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6482528 [patent_doc_number] => 20100008888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'CO-ADMINISTRATION OF CG250 AND IL-2 OR IFN-ALPHA FOR TREATING CANCER SUCH AS RENAL CELL CARCINOMAS' [patent_app_type] => utility [patent_app_number] => 12/559839 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4751 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008888.pdf [firstpage_image] =>[orig_patent_app_number] => 12559839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985558 [patent_doc_number] => 20110097756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'APEX AS A MARKER FOR LUNG CANCER' [patent_app_type] => utility [patent_app_number] => 12/556879 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10355 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097756.pdf [firstpage_image] =>[orig_patent_app_number] => 12556879 [rel_patent_id] =>[rel_patent_doc_number] =>)